Faeth Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Five
Faeth Therapeutics, Inc. (FTH) had Lessee, Operating Lease, Liability, to be Paid, Year Five of $59.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2023-03-29
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $59.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $1.41M.
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Five $1.42M.
- 2021-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Five $1.41M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2022-12-31 | $59.00K 10-K · filed 2023-03-29 |
| 2021-12-31 | $1.41M 10-K · filed 2022-03-15 |
| 2021-09-30 | $1.42M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.41M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $657.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |